デフォルト表紙
市場調査レポート
商品コード
1465117

女性骨盤インプラント市場:製品タイプ、適応症、エンドユーザー別-2024~2030年の世界予測

Female Pelvic Implants Market by Product Type (Vaginal Graft Implants, Vaginal Mesh Implants, Vaginal Sling), Indication (Pelvic Organ Prolapse, Stress Urinary Incontinence), End User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
女性骨盤インプラント市場:製品タイプ、適応症、エンドユーザー別-2024~2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性骨盤インプラント市場規模は2023年に9億7,232万米ドルと推定され、2024年には10億1,559万米ドルに達すると予測され、CAGR 4.76%で2030年には13億4,729万米ドルに達すると予測されます。

女性骨盤インプラントは、骨盤臓器脱(POP)やストレス性尿失禁(SUI)を含む骨盤底障害の治療専用に設計された医療機器です。これらの疾患は、出産や手術、加齢によって引き起こされることが多く、骨盤底の構造や強度に影響を及ぼします。合成メッシュや生物学的材料を含むインプラントは、膀胱、子宮、腸を含む骨盤内臓器を支え、損傷したり弱くなったりした骨盤底筋や組織を修復または補強するために外科的に挿入されます。世界的に女性の間で骨盤底障害が増加していることから、骨盤インプラントのニーズが高まっています。ヘルスケアインフラの改善と骨盤底障害に対する意識の高まりが、女性用骨盤インプラント市場の成長に寄与しています。しかし、メッシュインプラントの安全性に関する規制上の課題や過去の訴訟が、市場成長のかなりの抑制要因となっています。さらに、骨盤インプラント手術を効果的に行うための十分な訓練を受けた外科医が不足しているため、女性が利用できる治療の選択肢が限られており、メッシュのびらん、感染、インプラントの拒絶反応などの合併症が報告されており、患者の不快感や再手術の必要性につながっています。しかし、より安全で生体適合性の高い材料の研究を続けることで、合併症を減らし、患者の転帰を改善することができ、大きな成長機会がもたらされます。侵襲の少ない手術手技の開拓は、患者の受容性を高め、骨盤インプラント市場を拡大する可能性が高いです。

主な市場の統計
基準年[2023] 9億7,232万米ドル
予測年[2024] 10億1,559万米ドル
予測年 [2030] 13億4,729万米ドル
CAGR(%) 4.76%

製品タイプ:ストレス性尿失禁の治療効果により膣スリングの使用が拡大

膣グラフトインプラントは、骨盤臓器脱(POP)やストレス性尿失禁の治療や管理に使用される手術器具です。これらのインプラントは、弱くなった骨盤底筋や臓器をさらに支えるように設計されています。ポリプロピレンのような合成材料から作られることもあれば、自己由来(患者自身の体から)、異種由来(異なる種から)、同種由来(同じ種から)の生物学的材料から作られることもあります。膣グラフトインプラントの主な目的は、正常な骨盤底機能と解剖学的構造を回復させ、患者の生活の質を向上させることです。腟メッシュインプラントは、合成の非吸収性メッシュで特別に作られた腟移植インプラントのサブセットです。骨盤臓器脱やストレス性尿失禁などの症状の外科的治療に一般的に使用されます。これらのインプラントは、骨盤底の弱くなった構造を永久的に補強するように設計されています。膣スリングは、合成メッシュまたは生物学的材料のストリップを利用して、尿道周囲に支持スリングを作る手術法です。この手術は特に、尿道をさらにサポートすることで、運動中や咳、くしゃみの際に起こる不随意的な尿漏れを防ぐことを目的としています。膣スリングはその有効性が高く評価されており、ストレス性尿失禁に悩む女性に広く受け入れられている手術オプションとなっています。

エンドユーザー:総合的な施設と幅広い専門医を擁する病院による女性骨盤インプラントの採用が増加傾向にある

外来手術センター(ASC)は、診断や予防のためのソリューションや処置を含む、即日手術ケアを提供する近代的なヘルスケア施設です。ASCはその効率性と費用対効果で知られています。ASCは、女性骨盤インプラントを含む小手術を行うのに、便利で安全な環境を提供しています。病院は女性骨盤インプラントを使用する主要な場です。病院には、骨盤臓器脱や失禁の複雑な症例に対応できる、より包括的なインフラと幅広い専門家がいます。病院は高度な医療ソリューションと医療機器を備えており、術後ケアも充実しているため、骨盤インプラントを含む複雑な外科的介入に最も適した環境です。学際的なチームや集中治療室があることも、骨盤インプラントの応用における主導的な地位をさらに支えています。専門クリニックは、骨盤底障害の治療を行う泌尿生殖器科など、特定の医学分野や特定のサービスに焦点を当てています。これらのクリニックは、的を絞った治療を提供し、女性の骨盤の健康について深い専門知識を持つ専門医を雇用していることが多いです。専門クリニックは、骨盤インプラントを必要とする状態の診断と初期管理において重要な役割を果たしますが、実際のインプラント手術における役割は、施設の手術能力によって制限される場合があります。

地域別の洞察

南北アメリカ、特に米国とカナダでは、人口の高齢化、強固で高度に発達したヘルスケアインフラ、骨盤の健康問題に対する意識の高まりから、女性骨盤インプラントに対するニーズが高いです。米国では、学術機関と産業界の両方が主導する活発な調査活動が行われています。南北アメリカ地域における最近の特許は、インプラント材料と低侵襲的適用技術における革新を実証しています。中国、日本、インドなどを含むアジア太平洋地域は、女性用骨盤インプラント市場の急速な成長を目の当たりにしています。この成長に拍車をかけているのは、医療費の増加、骨盤障害に対する意識の高まり、ヘルスケアインフラの改善です。日本は先進的な研究と技術導入率の高さで際立っています。中国とインドは人口が多く、医療サービスへのアクセスが増加しているため、重要な市場として浮上しています。この地域では、現地製造や研究イニシアティブへの投資が目立ちます。欧州連合諸国は、先進的なヘルスケアシステムと骨盤の健康問題に対する広範な認識から恩恵を受け、革新的な骨盤インプラントの開発を促進しています。EUにおける研究開発は、助成金や大学、病院、企業間の共同研究によって支えられています。医療製品の製造と性能を管理するいくつかの厳しい規制が存在するため、女性骨盤インプラントの進歩のために高度に標準化された枠組みが構築されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは女性骨盤インプラント市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、女性骨盤インプラント市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.女性骨盤インプラント市場の市場規模および予測は?

2.女性骨盤インプラント市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.女性骨盤インプラント市場の技術動向と規制枠組みは?

4.女性骨盤インプラント市場における主要ベンダーの市場シェアは?

5.女性骨盤インプラント市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 女性の骨盤疾患の発生率の増加と女性の生殖および全体的な健康に関する意識
      • 女性のヘルスケアと医療サービスへのアクセスを拡大するための政府の取り組み
    • 抑制要因
      • 規制状況の理解と訴訟の発生の難しさ
    • 機会
      • 安全性、パフォーマンス、機能が向上した女性骨盤インプラントの開発が継続的に進歩している
      • 世界中で外科センターと不妊治療クリニックが拡大
    • 課題
      • 十分な訓練を受けた外科医の不足とパフォーマンスの問題
  • 市場セグメンテーション分析
    • 製品タイプ:腹圧性尿失禁の治療に効果があることから膣スリングの使用が拡大
    • エンドユーザー:病院の総合的な設備と幅広い専門医の存在により、女性骨盤インプラントの採用が拡大
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 女性骨盤インプラント市場:製品タイプ別

  • 膣移植インプラント
  • 膣メッシュインプラント
  • 膣スリング

第7章 女性骨盤インプラント市場:適応症別

  • 骨盤臓器脱
  • 腹圧性尿失禁

第8章 女性骨盤インプラント市場:エンドユーザー別

  • 外来手術センター
  • 病院
  • 専門クリニック

第9章 南北アメリカの女性骨盤インプラント市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の女性骨盤インプラント市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの女性骨盤インプラント市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析(2023年)
  • FPNVポジショニングマトリックス(2023年)
  • 競合シナリオ分析
    • Caldera Medical、Premier Incと女性医療および外科的失禁の専門分野に関する契約を締結
    • CurvaFix、骨盤骨折治療に用いられる湾曲手術機器の強化に向け3,900万米ドルを調達
    • FemTherapeuticsが患者固有の婦人科用義肢で女性の健康を促進するために180万米ドルを調達
  • 戦略分析と提言

第13章 競争力のあるポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. FEMALE PELVIC IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE PELVIC IMPLANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FEMALE PELVIC IMPLANTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE PELVIC IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL GRAFT IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL GRAFT IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL MESH IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL MESH IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL SLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL SLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-9E71DF483B9B

[197 Pages Report] The Female Pelvic Implants Market size was estimated at USD 972.32 million in 2023 and expected to reach USD 1,015.59 million in 2024, at a CAGR 4.76% to reach USD 1,347.29 million by 2030.

Female pelvic implants are medical devices designed specifically for the treatment of pelvic floor disorders, including pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These conditions are often caused by childbirth, surgery, or aging, affecting the pelvic floor's structure and strength. The implants, which include synthetic mesh or biological materials, are surgically inserted to support the pelvic organs, including the bladder, uterus, and bowel, and to repair or reinforce the damaged or weakened pelvic floor muscles and tissues. The rising cases of pelvic floor disorders among women globally create a need for pelvic implants. Improved healthcare infrastructure and heightened awareness about pelvic floor disorders have contributed to the growth of the female pelvic implant market. However, regulatory challenges and historical lawsuits related to safety concerns of mesh implants pose considerable restraints on market growth. Moreover, the shortage of adequately trained surgeons to perform pelvic implant surgeries effectively limits the treatment options available to women, and complications such as mesh erosion, infection, and implant rejection have been reported, leading to patient discomfort and the need for revision surgeries. However, continued research into safer, more biocompatible materials can reduce complications and improve patient outcomes, presenting significant growth opportunities. The development of less invasive surgical techniques would likely increase patient acceptance and widen the market for pelvic implants.

KEY MARKET STATISTICS
Base Year [2023] USD 972.32 million
Estimated Year [2024] USD 1,015.59 million
Forecast Year [2030] USD 1,347.29 million
CAGR (%) 4.76%

Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence

Vaginal graft implants are surgical devices used in the treatment and management of pelvic organ prolapse (POP) and stress urinary incontinence. These implants are designed to provide additional support to the weakened pelvic floor muscles and organs. They can be made from synthetic materials, such as polypropylene, or biological materials, which can be either autologous (from the patient's own body), heterologous (from a different species), or allogeneic (from the same species). The primary goal of vaginal graft implants is to restore normal pelvic floor function and anatomy, thereby improving the patient's quality of life. Vaginal mesh implants are a subset of vaginal graft implants specifically constructed from synthetic, non-absorbable mesh. They are commonly used for the surgical treatment of conditions, including pelvic organ prolapse and stress urinary incontinence. These implants are designed to provide a permanent reinforcement to the weakened structures of the pelvic floor. The vaginal sling is a surgical procedure that utilizes a strip of synthetic mesh or biological material to create a supportive sling around the urethra. This procedure is specifically aimed at preventing involuntary urine leakage that occurs during physical activities, coughing, or sneezing by providing additional support to the urethra. Vaginal slings are highly regarded for their efficacy and have become a widely accepted surgical option for women suffering from stress urinary incontinence.

End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists

Ambulatory surgical centers (ASCs) are modern healthcare structures that provide same-day surgical care, including diagnostic and preventive solutions and procedures. ASCs are known for their efficiency and cost-effectiveness. They offer a convenient and safe environment for the performance of minor surgeries, including those involving female pelvic implants. Hospitals are the primary setting for the use of female pelvic implants. They have a more comprehensive infrastructure and a broader range of specialists to manage complex cases of pelvic organ prolapse and incontinence. Hospitals are equipped with advanced medical solutions and equipment and offer extensive postoperative care, making them the most suitable environment for complex surgical interventions involving pelvic implants. The availability of multi-disciplinary teams and intensive care units further supports their leading position in the application of these implants. Specialty clinics focus on particular fields of medicine or specific services, including urogynecology, which involves the treatment of pelvic floor disorders. These clinics provide targeted care and often employ specialists with deep expertise in female pelvic health. While specialty clinics play a crucial role in the diagnosis and initial management of conditions necessitating pelvic implants, their role in the actual implantation procedures may be limited by the surgical capacity of the facility.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a high need for female pelvic implants due to aging populations, robust and highly developed healthcare infrastructure, and increasing awareness of pelvic health issues. The U.S. exhibits robust research activities led by both academic institutions and industry players. Recent patents in the Americas region demonstrate innovations in implant materials and minimally invasive application techniques. The Asia Pacific region, including China, Japan, India, and other countries, is witnessing rapid growth in the female pelvic implant market. This growth is spurred by increasing healthcare expenditures, rising awareness of pelvic disorders, and improving healthcare infrastructure. Japan stands out for its advanced research and a high rate of technology adoption. China and India are emerging as significant markets due to their large populations and increasing access to healthcare services. Investments in local manufacturing and research initiatives are prominent in this region. European Union countries benefit from advanced healthcare systems and widespread awareness of pelvic health issues, driving the development of innovative pelvic implants. Research and development in the EU are supported by grants and collaborations among universities, hospitals, and companies. The presence of several stringent regulations governing the manufacture and performance of medical products creates a highly standardized framework for the progress of female pelvic implants.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Female Pelvic Implants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Female Pelvic Implants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Female Pelvic Implants Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, B. Braun of America Inc., Betatech Medical, Boston Scientific Corporation, Caldera Medical, CARDIOLINK S.L. by CB Scientific, Inc., Coloplast Corp., Cook Group Incorporated, CurvaFix, Inc., Medtronic, Narang Medical Limited, Neomedic Int, Olympus Corporation, PALEX MEDICAL, S.A, pfm Medical GmbH, PROMEDON GmbH, SARS Cousin Biotech, Tecomet, Inc., Zimmer Biomet, and ZSI Surgical Implants S.R.L..

Market Segmentation & Coverage

This research report categorizes the Female Pelvic Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Vaginal Graft Implants
    • Vaginal Mesh Implants
    • Vaginal Sling
  • Indication
    • Pelvic Organ Prolapse
    • Stress Urinary Incontinence
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Female Pelvic Implants Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Female Pelvic Implants Market?

3. What are the technology trends and regulatory frameworks in the Female Pelvic Implants Market?

4. What is the market share of the leading vendors in the Female Pelvic Implants Market?

5. Which modes and strategic moves are suitable for entering the Female Pelvic Implants Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
      • 5.1.1.2. Government initiatives to expand access to healthcare and medical services for women
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in navigating the regulatory landscape and incidences of lawsuits
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
      • 5.1.3.2. Expansion of surgical centers and fertility clinics across the world
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of adequately trained surgeons and performance issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence
    • 5.2.2. End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Female Pelvic Implants Market, by Product Type

  • 6.1. Introduction
  • 6.2. Vaginal Graft Implants
  • 6.3. Vaginal Mesh Implants
  • 6.4. Vaginal Sling

7. Female Pelvic Implants Market, by Indication

  • 7.1. Introduction
  • 7.2. Pelvic Organ Prolapse
  • 7.3. Stress Urinary Incontinence

8. Female Pelvic Implants Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Female Pelvic Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Female Pelvic Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Female Pelvic Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Caldera Medical awarded Specialty Women's Health and Surgical Incontinence contract Agreement with Premier Inc
    • 12.3.2. CurvaFix lands USD 39 million to boost curved surgical device used for pelvic fracture treatment
    • 12.3.3. FemTherapeutics Raises USD 1.8 Million To Advance Women's Health With Its Patient-Specific Gynecological Prosthetics
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio